Skip to content

Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center

Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02867995
Enrollment
39
Registered
2016-08-16
Start date
2017-03-23
Completion date
2018-03-30
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

glaucoma drop aid

Brief summary

The purpose of this study is to determine whether glaucoma drop aids will be cost-effective in delivery of ophthalmic medications by improving medication compliance, visual function, and even decreasing medication waste in the patient population at Boston Medical Center (BMC).

Detailed description

Patients being treated for their glaucoma at BMC's Yawkey Eye Clinic will be selected according to the inclusion and exclusion criteria. The three drop aids used in this study will be the Fabrication Autodrop Eye Drop Guide, Owen Mumford OP 6100 Autosqueeze, and the Simply Touch Eye Drop Applicator. Patients will be randomly placed on one of these drops aids for a total of 3 study groups or the no drop aid control, for a total of 4 groups. Prior to use of the drop aid, patients will be instructed on how to use the drop aid by a resident physician and a pre- intervention intraocular pressure check will be performed by the resident physician using an applicator. Intraocular pressure is the only adjustable risk factor for glaucoma; thus, glaucoma treatments slow progression of glaucoma by reducing intraocular pressure. In addition, patients will be requested to deliver their drops with the drop aid with every use. Furthermore, each patient will record the number of days taken to complete the glaucoma medication bottle while using the drop aid. At the 3 and 6 week marks, the patient will fill out a satisfaction survey. Patients will need to return to the clinic at the 6 week mark and can fill out the satisfaction survey at the clinic in addition to checking the intraocular pressure post-intervention. Thus, the number of subject contact will be two, pre and post-intervention, the duration of participation for each subject will be 6 weeks, and the patient will also be required to fill out two satisfaction surveys. The effectiveness of the drop aids will be compared to the two controls and measured with any changes in intraocular pressure readings, length of time to medication completion, and patient satisfaction according to the surveys.

Interventions

DEVICEEye Drop Aid

Fabrication Autodrop Eye Drop Guide,Owen Mumford OP 6100 Autosqueeze, and the Simply Touch Eye Drop Applicator

Sponsors

Boston Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* age 18 years or greater * Currently on the same topical medication for treatment of glaucoma for a minimum of two months * Patient of Boston University eye Associates * Agrees to use the drop aid with each delivery, return to the clinic after 6 weeks of using the drop aid, document completion of medication drops and fill out survey at the end of the 6 weeks

Exclusion criteria

* Less than age 18 years * Changes glaucoma medication within the past two month or recent glaucoma surgery * Older than 89 years of age * Not a patient of the Boston University eye associate

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Assessed for Intraocular Pressure Changebaseline and 6 weeksIntraocular pressure (IOP) is measured by Goldman applanation in patients and is expressed in mmHg. The IOP, which is a routine check in the ophthalmic exam, was measured in the eye drop aid group prior to starting drop aid use and at six weeks while using drop aids. IOP was measured at baseline and at 6 weeks in the control group. A significant increase in IOP is defined as an increase of 4 mmHg or more, a significant decreases in IOP is defined as a decrease of 4mmHg or more. No significant change in the IOP is a change between 1-3 mmHg.

Secondary

MeasureTime frameDescription
Number of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye Drops6 weeksA question on the six week survey asked approximately how often the participant missed their eye when inserting eye drops. Response options included: missed inserting eye drops 0 times, missed inserting eye drops 1 time, missed inserting eye drops 2 times, or missed inserting eye drops 3 or more times.
Satisfaction With Eye Drop Aid6 weeksA question on the six week survey asked if the participant liked the eye drop aid. Response options included: liked the drop aid long term, did not like the drop aid, or did not use a drop aid. Results were stratified by the three drop aid types (Fabrication Autodrop Eye Drop Guide, Owen Mumford OP 6100 Autosqueeze, or the Simply Touch Eye Drop Applicator).
Intent to Use Eye Drop Aid Long Term6 weeksA question on the six week survey asked if the participant intended to use the eye drop aid long term. Response options included: would use the drop aid long term, would not use the drop aid long term, or did not use a drop aid. Results were stratified by the three drop aid types (Fabrication Autodrop Eye Drop Guide, Owen Mumford OP 6100 Autosqueeze, or the Simply Touch Eye Drop Applicator).

Countries

United States

Participant flow

Participants by arm

ArmCount
No Drop Aid
No glaucoma drop aid received- control
9
Drop Aid
Participants could be placed into one of the drop aid groups (Fabrication Autodrop Eye Drop Guide,Owen Mumford OP 6100 Autosqueeze, or the Simply Touch Eye Drop Applicator) Eye Drop Aid: Fabrication Autodrop Eye Drop Guide,Owen Mumford OP 6100 Autosqueeze, and the Simply Touch Eye Drop Applicator
30
Total39

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up02
Overall StudyWithdrawal by Subject01

Baseline characteristics

CharacteristicNo Drop AidTotalDrop Aid
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
7 Participants20 Participants13 Participants
Age, Categorical
Between 18 and 65 years
2 Participants19 Participants17 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants1 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants38 Participants29 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Glaucoma9 Participants39 Participants30 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
5 Participants26 Participants21 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants6 Participants4 Participants
Race (NIH/OMB)
White
1 Participants6 Participants5 Participants
Region of Enrollment
United States
9 participants39 participants30 participants
Sex: Female, Male
Female
2 Participants18 Participants16 Participants
Sex: Female, Male
Male
7 Participants21 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 90 / 30
other
Total, other adverse events
0 / 90 / 30
serious
Total, serious adverse events
0 / 90 / 30

Outcome results

Primary

Number of Participants Assessed for Intraocular Pressure Change

Intraocular pressure (IOP) is measured by Goldman applanation in patients and is expressed in mmHg. The IOP, which is a routine check in the ophthalmic exam, was measured in the eye drop aid group prior to starting drop aid use and at six weeks while using drop aids. IOP was measured at baseline and at 6 weeks in the control group. A significant increase in IOP is defined as an increase of 4 mmHg or more, a significant decreases in IOP is defined as a decrease of 4mmHg or more. No significant change in the IOP is a change between 1-3 mmHg.

Time frame: baseline and 6 weeks

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participants Assessed for Intraocular Pressure ChangeSignificant increase in IOP0 Participants
ControlNumber of Participants Assessed for Intraocular Pressure ChangeSignificant decrease in IOP4 Participants
ControlNumber of Participants Assessed for Intraocular Pressure ChangeNo change in IOP5 Participants
Eye Drop AidsNumber of Participants Assessed for Intraocular Pressure ChangeSignificant increase in IOP4 Participants
Eye Drop AidsNumber of Participants Assessed for Intraocular Pressure ChangeSignificant decrease in IOP8 Participants
Eye Drop AidsNumber of Participants Assessed for Intraocular Pressure ChangeNo change in IOP15 Participants
Secondary

Intent to Use Eye Drop Aid Long Term

A question on the six week survey asked if the participant intended to use the eye drop aid long term. Response options included: would use the drop aid long term, would not use the drop aid long term, or did not use a drop aid. Results were stratified by the three drop aid types (Fabrication Autodrop Eye Drop Guide, Owen Mumford OP 6100 Autosqueeze, or the Simply Touch Eye Drop Applicator).

Time frame: 6 weeks

Population: Participants include all enrolled patients who completed the study. The drop aid group was stratified into the three types of aids- AutoDrop, Autosqueeze, and Simply Touch.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlIntent to Use Eye Drop Aid Long TermWould use Drop Aid long term9 Participants
ControlIntent to Use Eye Drop Aid Long TermWould not use Drop Aid long term1 Participants
ControlIntent to Use Eye Drop Aid Long TermDid not use Drop Aid0 Participants
Eye Drop AidsIntent to Use Eye Drop Aid Long TermDid not use Drop Aid0 Participants
Eye Drop AidsIntent to Use Eye Drop Aid Long TermWould use Drop Aid long term6 Participants
Eye Drop AidsIntent to Use Eye Drop Aid Long TermWould not use Drop Aid long term2 Participants
Simply TouchIntent to Use Eye Drop Aid Long TermWould not use Drop Aid long term4 Participants
Simply TouchIntent to Use Eye Drop Aid Long TermWould use Drop Aid long term3 Participants
Simply TouchIntent to Use Eye Drop Aid Long TermDid not use Drop Aid2 Participants
ControlIntent to Use Eye Drop Aid Long TermDid not use Drop Aid9 Participants
ControlIntent to Use Eye Drop Aid Long TermWould use Drop Aid long term0 Participants
ControlIntent to Use Eye Drop Aid Long TermWould not use Drop Aid long term0 Participants
Secondary

Number of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye Drops

A question on the six week survey asked approximately how often the participant missed their eye when inserting eye drops. Response options included: missed inserting eye drops 0 times, missed inserting eye drops 1 time, missed inserting eye drops 2 times, or missed inserting eye drops 3 or more times.

Time frame: 6 weeks

Population: Participants include those who were compliant with their drop aid device throughout the length of their medication bottle, as well as those who were non-compliant with their device group.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsMissed inserting eye drops 1 times5 Participants
ControlNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsMissed inserting eye drops 3 or more times1 Participants
ControlNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsMissed inserting eye drops 2 times0 Participants
ControlNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsNo Data Available0 Participants
ControlNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsMissed inserting eye drops 0 times3 Participants
Eye Drop AidsNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsNo Data Available6 Participants
Eye Drop AidsNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsMissed inserting eye drops 0 times10 Participants
Eye Drop AidsNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsMissed inserting eye drops 1 times8 Participants
Eye Drop AidsNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsMissed inserting eye drops 2 times1 Participants
Eye Drop AidsNumber of Participants Stratified by the Number of Times Eye Was Missed When Inserting Eye DropsMissed inserting eye drops 3 or more times2 Participants
Secondary

Satisfaction With Eye Drop Aid

A question on the six week survey asked if the participant liked the eye drop aid. Response options included: liked the drop aid long term, did not like the drop aid, or did not use a drop aid. Results were stratified by the three drop aid types (Fabrication Autodrop Eye Drop Guide, Owen Mumford OP 6100 Autosqueeze, or the Simply Touch Eye Drop Applicator).

Time frame: 6 weeks

Population: Participants include all enrolled patients who completed the study. The drop aid group was stratified into the three types of aids- AutoDrop, Autosqueeze, and Simply Touch.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlSatisfaction With Eye Drop AidLiked Drop Aid3 Participants
ControlSatisfaction With Eye Drop AidDid not use Drop Aid0 Participants
ControlSatisfaction With Eye Drop AidDid Not Like Drop Aid4 Participants
Eye Drop AidsSatisfaction With Eye Drop AidLiked Drop Aid6 Participants
Eye Drop AidsSatisfaction With Eye Drop AidDid not use Drop Aid0 Participants
Eye Drop AidsSatisfaction With Eye Drop AidDid Not Like Drop Aid2 Participants
Simply TouchSatisfaction With Eye Drop AidDid Not Like Drop Aid4 Participants
Simply TouchSatisfaction With Eye Drop AidLiked Drop Aid3 Participants
Simply TouchSatisfaction With Eye Drop AidDid not use Drop Aid2 Participants
ControlSatisfaction With Eye Drop AidLiked Drop Aid0 Participants
ControlSatisfaction With Eye Drop AidDid not use Drop Aid9 Participants
ControlSatisfaction With Eye Drop AidDid Not Like Drop Aid0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026